CTGF is a therapeutic target for metastatic melanoma

Oncogene

Volumn 33, Issue 9, 2014, Pages 1093-1100

  Finger, E C ^a   Cheng, C F ^a   Williams, T R ^a   Rankin, E B ^a   Bedogni, B ^b   Tachiki, L ^a   Spong, S ^c   Giaccia, A J ^a   Powell, M B ^a  

^a STANFORD UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FIBROGEN INC   (United States)

Author keywords

connective tissue growth factor (CTGF); hypoxia; invasion; melanoma; metastasis; therapeutic target

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; FG 3019; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CUTANEOUS MELANOMA; DRUG TARGETING; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LUNG METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS INHIBITION; METASTATIC MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

MUS;

ANIMALS; ANOXIA; ANTIBODIES, MONOCLONAL; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MATRIX METALLOPROTEINASE 9; MELANOMA; MICE; MICE, SCID;

EID: 84896716986     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.47     Document Type: Article

References (43)

1. Haluska FG, Tsao H, Wu H, Haluska FS, Lazar A, Goel V. Genetic alterations in signaling pathways in melanoma. Clin Cancer Res 2006; 12(7 Pt 2): 2301s-2307s.
2. Aguissa-Toure AH, Li G. Genetic alterations of PTEN in human melanoma. Cell Mol Life Sci 2012; 69: 1475-1491.
3. Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS 2007; 115: 1161-1176.
4. Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med 2012; 367: 1694-1703.
5. Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012; 487: 505-509.
6. Bedogni B, Powell MB. Hypoxia, melanocytes and melanoma-survival and tumor development in the permissive microenvironment of the skin. Pigment Cell Melanoma Res 2009; 22: 166-174.
7. Lartigau E, Randrianarivelo H, Avril MF, Margulis A, Spatz A, Eschwege F et al. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res 1997; 7: 400-406.
8. Finger EC, Giaccia AJ. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 2010; 29: 285-293.
9. Bindra RS, Schaffer PJ, Meng A, Woo J, Maseide K, Roth ME et al. Alterations in DNA repair gene expression under hypoxia: Elucidating the mechanisms of hypoxia-induced genetic instability. Ann N Y Acad Sci 2005; 1059: 184-195.
10. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
11. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
12. Chan DA, Giaccia AJ. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev. 2007; 26: 333-339.
13. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15: 678-685.
14. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, Ragoussis J et al. Genomewide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem 2009; 284: 16767-16775.
15. Dhar A, Ray A. The CCN family proteins in carcinogenesis. Exp Oncol 2010; 32: 2-9.
16. Chu CY, Chang CC, Prakash E, Kuo ML. Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci 2008; 15: 675-685.
17. Hall-Glenn F, De Young RA, Huang BL, van Handel B, Hofmann JJ, Chen TT et al. CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis. PLoS One 2012; 7: E30562.
18. Hubble J, Demeter J, Jin H, Mao M, Nitzberg M, Reddy TB et al. Implementation of Genepattern within the Stanford Microarray Database. Nucleic Acids Res 2009; 37(Database issue): D898-D901.
19. Payne SL, Hendrix MJ, Kirschmann DA. Paradoxical roles for lysyl oxidases in cancer-A prospect. J Cell Biochem 2007; 101: 1338-1354.
20. Zhang H, Akman HO, Smith EL, Zhao J, Murphy-Ullrich JE, Batuman OA. Cellular response to hypoxia involves signaling via Smad proteins. Blood 2003; 101: 2253-2260.
21. Braig S, Wallner S, Junglas B, Fuchshofer R, Bosserhoff AK. CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. Br J Cancer 2011; 105: 231-238.
22. Riker AI, Enkemann SA, Fodstad O, Liu S, Ren S, Morris C et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008; 1: 13.
23. Dornhofer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N et al. Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2006; 66: 5816-5827.
24. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004; 287: F1223-F1232.
25. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T et al. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002; 23: 769-776.
26. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000; 58: 2351-2366.
27. Patel B, Khaliq A, Jarvis-Evans J, McLeod D, Mackness M, Boulton M. Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. Biochem Mol Biol Int 1994; 34: 639-644.
28. Cicha I, Goppelt-Struebe M. Connective tissue growth factor: Context-dependent functions and mechanisms of regulation. Biofactors 2009; 35: 200-208.
29. Samarin J, Wessel J, Cicha I, Kroening S, Warnecke C, Goppelt-Struebe M. FoxO proteins mediate hypoxic induction of connective tissue growth factor in endothelial cells. J Biol Chem 2010; 285: 4328-4336.
30. Perbal B. CCN proteins: Multifunctional signalling regulators. Lancet 2004; 363: 62-64.
31. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993; 327: 125-130.
32. Chujo S, Shirasaki F, Kondo-Miyazaki M, Ikawa Y, Takehara K. Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis. J Cell Physiol 2009; 220: 189-195.
33. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 2004; 10: 2072-2081.
34. Koliopanos A, Friess H, di Mola FF, Tang WH, Kubulus D, Brigstock D et al. Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J Surg 2002; 26: 420-427.
35. Liu LY, Han YC, Wu SH, Lv ZH. Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer. World J Gastroenterol 2008; 14: 2110-2114.
36. Sala-Torra O, Gundacker HM, Stirewalt DL, Ladne PA, Pogosova-Agadjanyan EL, Slovak ML et al. Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia. Blood 2007; 109: 3080-3083.
37. Shakunaga T, Ozaki T, Ohara N, Asaumi K, Doi T, Nishida K et al. Expression of connective tissue growth factor in cartilaginous tumors. Cancer 2000; 89: 1466-1473.
38. Chen PP, Li WJ, Wang Y, Zhao S, Li DY, Feng LY et al. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS One 2007; 2: E534.
39. Bennewith KL, Huang X, Ham CM, Graves EE, Erler JT, Kambham N et al. The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 2009; 69: 775-784.
40. Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ, Powell MB. Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 2008; 118: 3660-3670.
41. Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, Giaccia AJ. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008; 14: 90-102.
42. Chan DA, Kawahara TL, Sutphin PD, Chang HY, Chi JT, Giaccia AJ. Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell 2009; 15: 527-538.
43. Zhang B, Zhou KK, Ma JX. Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/betacatenin pathway. Diabetes 2010; 59: 1809-1816.